D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 19,634 327 World Ranking 14039 National Ranking 178

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Gene

Her primary areas of investigation include Immunology, Chronic lymphocytic leukemia, Internal medicine, Leukemia and Immunophenotyping. The Immunology study combines topics in areas such as Guideline, Haematopoiesis and Virology. The various areas that she examines in her Chronic lymphocytic leukemia study include Cancer research, Stem cell marker, B cell, Loss of heterozygosity and Single-nucleotide polymorphism.

Her research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology. Her Leukemia research incorporates themes from Alemtuzumab and Pentostatin. Estella Matutes has researched Immunophenotyping in several fields, including Lymphoproliferative disorders, Pathology, Clinical value, CD5 and Acute leukemia.

Her most cited work include:

  • Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). (1153 citations)
  • Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial (642 citations)
  • A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia (315 citations)

What are the main themes of her work throughout her whole career to date?

Estella Matutes spends much of her time researching Immunology, Internal medicine, Pathology, Chronic lymphocytic leukemia and Lymphoma. As part of the same scientific family, she usually focuses on Immunology, concentrating on Stem cell marker and intersecting with Cancer research. Her work deals with themes such as Gastroenterology, Surgery and Oncology, which intersect with Internal medicine.

Her studies deal with areas such as Fluorescence in situ hybridization and Splenic marginal zone lymphoma as well as Pathology. Her Chronic lymphocytic leukemia study incorporates themes from Trisomy, Locus, Mutation and B cell. Her Lymphoma research is multidisciplinary, relying on both Serology, Chemotherapy and Splenectomy.

She most often published in these fields:

  • Immunology (36.45%)
  • Internal medicine (29.60%)
  • Pathology (27.10%)

What were the highlights of her more recent work (between 2011-2020)?

  • Immunology (36.45%)
  • Cancer research (12.77%)
  • Chronic lymphocytic leukemia (23.36%)

In recent papers she was focusing on the following fields of study:

Estella Matutes mostly deals with Immunology, Cancer research, Chronic lymphocytic leukemia, Leukemia and Internal medicine. She combines subjects such as Clinical trial, Disease and Gene expression profiling with her study of Immunology. Her study looks at the relationship between Cancer research and fields such as Hairy cell leukemia, as well as how they intersect with chemical problems.

Her work carried out in the field of Chronic lymphocytic leukemia brings together such families of science as Cancer, Newly diagnosed, Immunoglobulin levels, Pathology and Hypogammaglobulinemia. Her research integrates issues of Mutation, Exome sequencing and Survival analysis in her study of Leukemia. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Oncology.

Between 2011 and 2020, her most popular works were:

  • Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial (143 citations)
  • Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia (100 citations)
  • Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial (91 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Her main research concerns Internal medicine, Leukemia, Chronic lymphocytic leukemia, Immunology and Cancer research. Her research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Survival rate and Surgery. Her Leukemia study combines topics in areas such as Chlorambucil, Cyclophosphamide, Fludarabine, Cancer and Mutation.

The concepts of her Chronic lymphocytic leukemia study are interwoven with issues in Genome-wide association study, Imatinib mesylate, Hematology, Locus and Survival analysis. The various areas that Estella Matutes examines in her Immunology study include Oncology, Germline, Philadelphia chromosome, Genotype and Genetic association. Her Cancer research study incorporates themes from Cladribine, Lymphocytosis, Immunophenotyping, Hairy Cell and Bone marrow.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).

Bene Mc;Castoldi G;Knapp W;Ludwig Wd.
Leukemia (1995)

2003 Citations

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

D Catovsky;S Richards;E Matutes;D Oscier.
The Lancet (2007)

893 Citations

Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.

E Matutes;V Brito-Babapulle;J Swansbury;J Ellis.
Blood (1991)

596 Citations

Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

Elisabeth J. Moreau;Estella Matutes;Roger P. A’Hern;Alison M. Morilla.
American Journal of Clinical Pathology (1997)

475 Citations

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

Maria Chiara Di Bernardo;Dalemari Crowther-Swanepoel;Peter Broderick;Emily Webb.
Nature Genetics (2008)

426 Citations

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

Claire E. Dearden;Estella Matutes;Bruno Cazin;Geir E. Tjønnfjord.
Blood (2001)

407 Citations

A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.

Jenny Orchard;Richard Garand;Zadie Davis;Gavin Babbage.
Blood (2003)

387 Citations

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H.

Lia Ginaldi;T Massimo De Martinis;Estella Matutes;Nahla Farahat.
Leukemia Research (1998)

382 Citations

Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial

David Gonzalez;Pilar Martinez;Rachel Wade;Sarah Hockley.
Journal of Clinical Oncology (2011)

330 Citations

Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification

Estella Matutes;Winfried F. Pickl;Mars van't Veer;Ricardo Morilla.
Blood (2011)

322 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Estella Matutes

Daniel Catovsky

Daniel Catovsky

Institute of Cancer Research

Publications: 92

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 92

Michael Hallek

Michael Hallek

University of Cologne

Publications: 90

Susan O'Brien

Susan O'Brien

University of California, Irvine

Publications: 87

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 85

Elias Campo

Elias Campo

University of Barcelona

Publications: 81

David Oscier

David Oscier

Royal Bournemouth Hospital

Publications: 76

Stephan Stilgenbauer

Stephan Stilgenbauer

University of Ulm

Publications: 75

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 67

Richard S. Houlston

Richard S. Houlston

Institute of Cancer Research

Publications: 65

Gianluca Gaidano

Gianluca Gaidano

University of Eastern Piedmont Amadeo Avogadro

Publications: 63

Paolo Ghia

Paolo Ghia

Vita-Salute San Raffaele University

Publications: 63

Tadeusz Robak

Tadeusz Robak

Medical University of Lodz

Publications: 62

Emili Montserrat

Emili Montserrat

University of Barcelona

Publications: 60

Peter Hillmen

Peter Hillmen

St James's University Hospital

Publications: 54

Neil E. Kay

Neil E. Kay

Mayo Clinic

Publications: 54

Trending Scientists

King-Sun Fu

King-Sun Fu

Purdue University West Lafayette

Gilles Mailhot

Gilles Mailhot

Centre national de la recherche scientifique, CNRS

Vern L. Schramm

Vern L. Schramm

Albert Einstein College of Medicine

Irene J. Beyerlein

Irene J. Beyerlein

University of California, Santa Barbara

Beatrix E. Beisner

Beatrix E. Beisner

University of Quebec at Montreal

George Amato

George Amato

American Museum of Natural History

Michael R. Lappin

Michael R. Lappin

Colorado State University

Renato A. Mortara

Renato A. Mortara

Federal University of Sao Paulo

Harvey B. Pollard

Harvey B. Pollard

Uniformed Services University of the Health Sciences

Kohji Fukunaga

Kohji Fukunaga

Tohoku University

Elizabeth U. Canning

Elizabeth U. Canning

Imperial College London

Ping-Yee Law

Ping-Yee Law

University of Minnesota

F. J. Schmidlin

F. J. Schmidlin

National Aeronautics and Space Administration

Candice Hansen

Candice Hansen

Planetary Science Institute

Brian A. King

Brian A. King

National Oceanography Centre

Karl K. Szpunar

Karl K. Szpunar

Toronto Metropolitan University

Something went wrong. Please try again later.